SuperworthZimmer Biomet EPS ZBH
Diluted earnings per share by quarter and over the last twelve months, from 2008.
- Last 12 months, to Jun 30, 2026
- $4.11
- Latest quarter, Q2 FY26
- $1.03
- +34% on a year earlier
- Fiscal year 2025
- $3.54
- −20% on the year before
Zimmer Biomet's earnings per share was $4.11 over the twelve months to Jun 30, 2026, up 0% on a year earlier.
In its latest quarter, Q2 FY26, it was $1.03, up 34% on the same quarter a year before.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $3.54 | −20% |
| FY2024 | $4.45 | −9% |
| FY2023 | $4.89 | +345% |
| FY2022 | $1.10 | −42% |
| FY2021 | $1.90 | n/a |
| FY2020 | −$0.71 | −113% |
| FY2019 | $5.47 | n/a |
| FY2018 | −$1.88 | −121% |
| FY2017 | $8.88 | +492% |
| FY2016 | $1.50 | +108% |
| FY2015 | $0.72 | −83% |
| FY2014 | $4.20 | −5% |
| FY2013 | $4.43 | +3% |
| FY2012 | $4.29 | +7% |
| FY2011 | $4.02 | +35% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $1.03 | +34% | $4.11 | |
| Q1 FY26 | $1.22 | +34% | $3.85 | |
| Q4 FY25 | $0.70 | −42% | $3.54 | |
| Q3 FY25 | $1.16 | −6% | $4.04 | |
| Q2 FY25 | $0.77 | −35% | $4.11 | |
| Q1 FY25 | $0.91 | +8% | $4.52 | |
| Q4 FY24 | $1.20 | −40% | $4.45 | |
| Q3 FY24 | $1.23 | +60% | $5.26 | |
| Q2 FY24 | $1.18 | +18% | $4.80 | |
| Q1 FY24 | $0.84 | −24% | $4.62 | |
| Q4 FY23 | $2.01 | n/a | $4.89 | |
| Q3 FY23 | $0.77 | −16% | $2.26 |
Against its peers
Companies in Medical - Devices nearest Zimmer Biomet's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| ZBHZimmer Biomet | $4.11 | +0% a year |
| DXCMDexCom | $2.52 | +76% a year |
| GEHCGE HealthCare Technologies | $4.36 | −11% a year |
| EWEdwards Lifesciences | $1.74 | −75% a year |
| BSXBoston Scientific | $2.47 | +47% a year |
| LIVNLivaNova | $3.39 | |
| ITGRInteger | $3.66 | +61% a year |
| SYKStryker | $9.65 | +28% a year |
| MDTMedtronic | $4.07 | +12% a year |
| TMDXTransMedics | $3.84 | +99% a year |
| ABTAbbott Laboratories | $2.68 | −66% a year |
| Peer median | $3.52 |
Where Zimmer Biomet ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Zimmer Biomet
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.